Dr. Umphlett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 10th avenue
New York, NY 10019
Summary
- Dr. Melissa Umphlett is a pathologist in New York, NY and is affiliated with multiple hospitals in the area, including Mount Sinai West, Mount Sinai Beth Israel, and The Mount Sinai Hospital. She specializes in neuropathology, anatomic pathology, and clinical pathology.
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Neuropathology, 2017 - 2019
- University of Pennsylvania Health System Surgical PathologyFellowship, Selective Pathology, 2010 - 2011
- Washington Hospital CenterResidency, Pathology-Anatomic and Clinical, 2006 - 2010
- American University of the Caribbean School of MedicineClass of 2005
Certifications & Licensure
- NY State Medical License 2011 - 2025
- PA State Medical License 2010 - 2024
- CT State Medical License 2012 - 2014
- NJ State Medical License 2011 - 2013
- DC State Medical License 2005 - 2010
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 3 citationsGenetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma.Timothy E Richardson, Jamie M Walker, Dolores Hambardzumyan, Steven Brem, Kimmo J Hatanpaa
Acta Neuropathologica. 2024-07-16 - 3 citationsCDKN2A mutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytoma.Raquel T Yokoda, William S Cobb, Raymund L Yong, John F Crary, Mariano S Viapiano
Journal of Neuropathology and Experimental Neurology. 2023-09-20 - 4 citationsMismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma.Timothy E Richardson, Raquel T Yokoda, Omid Rashidipour, Meenakshi Vij, Matija Snuderl
Neuro-Oncology Advances. 2023-07-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: